SCHEMBL5557979

SCHEMBL5557979

Nc1ccc([N+](=O)[O-])c(-c2ccc(Cl)cc2Cl)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
HSD11B1 P28845 1/20 0.45
GSK3B P49841 4/20 0.43
GSK3A P49840 3/20 0.43
CDK1 P06493 2/20 0.43
CCNB2 O95067 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
NPBWR1 P48145 1/20 0.42
PDE7A Q13946 3/20 0.42
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 1/20 0.40
IDO1 P14902 1/20 0.40
APEX1 P27695 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5094069 0.88 MAPK1 (0.57) TSHRMAPK1HSD11B1GSK3BGSK3A
SCHEMBL4399102 0.78 GSK3B (0.67) TSHRMAPK1HSD11B1GSK3BGSK3A
SCHEMBL7700241 0.78 S1PR4 (0.42) TSHRMAPK1HSD11B1GSK3BGSK3A
SCHEMBL28753512 0.74 MAPK1 (0.50) TSHRMAPK1HSD11B1NPBWR1LMNA
SCHEMBL10771873 0.74 MAPK1 (0.53) TSHRMAPK1HSD11B1NPBWR1PDE7A
SCHEMBL29398960 0.72 TSHR (1.00) TSHRMAPK1PDE7ALMNAPOLB
SCHEMBL487215 0.72 TSHR (1.00) TSHRMAPK1PDE7ALMNAPOLB
SCHEMBL11198744 0.71 MAPT (0.45) TSHRMAPK1PDE7APOLBALDH1A1
SCHEMBL7026093 0.71 GSK3B (0.63) GSK3BGSK3ACDK1CCNB2CCNB1
Fluoride SCHEMBL4646971 0.70 TSHR (0.96) TSHRMAPK1PDE7ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490093-A4 METHODS AND COMPOSITIONS FOR THE TREATMENT OF ISCHEMIA NOVARTIS VACCINES & DIAGNOSTIC (US) 2007-04-11 EP disclosed
EP-1490093-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF ISCHEMIA CHIRON CORPORATION (US) 2004-12-29 EP disclosed
WO-2003074072-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF ISCHEMIA CHIRON CORPORATION (US) 2003-09-12 WO disclosed
EP-1317433-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2003-06-11 EP disclosed
WO-2002020495-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2002-03-14 WO disclosed